Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia-Reference-Cited by-同舟云学术

Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia

Published:2017-10 Issue: Volume:139 Page:762-772
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Diab Sarah,Abdelaziz Ahmad M.,Li Peng,Teo Theodosia,Basnet Sunita K.C.,Noll Ben,Rahaman Muhammed H.,Lu Jingfeng,Hou Jinqiang,Yu Mingfeng,Le Bich T.,Albrecht Hugo,Milne Robert W.,Wang Shudong^ORCID

Funder

Australia Government National Health and Medical Research Council

South Australian Health and Medical Research Institute

Beat Cancer Project Principal Cancer Research Fellowship

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference42 articles.

1. FLT3 as a therapeutic target in AML: still challenging after all these years

2. An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment

3. Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias

4. Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome

5. Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An efficient synthesis of (E)-3-[(dimethylamino)methylidene]furan-2(3H)-thiones and transamination reactions thereof;Chemistry of Heterocyclic Compounds;2024-04

2. Design, synthesis, and biological evaluation of carbonyl-hydrazine-1-carboxamide derivatives as anti-hepatic fibrosis agents targeting Nur77;Bioorganic Chemistry;2023-11

3. Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia;BMC Chemistry;2023-07-12

4. Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition;Cancers;2023-02-07

5. In silico approach of novel HPPD/PDS dual target inhibitors by pharmacophore, AILDE and molecular docking;Journal of the Taiwan Institute of Chemical Engineers;2023-02